NEW YORK (GenomeWeb News) – Gen-Probe announced after the close of the market on Friday it will be holding a special shareholder meeting on July 31 during which shareholders will vote on the proposed $3.7 billion acquisition of the company by Hologic.
Hologic's bid for Gen-Probe, under which it would pay $82.75 per share of Gen-Probe's stock, was announced in April. Earlier this month, the deal cleared antitrust review by US regulators.
The special meeting will be held at Gen-Probe's headquarters in San Diego. Shareholders of Gen-Probe stock as of the end of the business day on June 29 are eligible to vote on the deal.
Planning efforts to integrate Gen-Probe into Hologic have already begun, and in June, a Hologic official said that once the deal is completed Gen-Probe would become the "hub" of Hologic's diagnostics business.